Verhoeff's query: Is vitamin D effective against retinoblastoma?

D. M. Albert, A. M. Saulenas, S. M. Cohen

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

In 1966, Verhoeff suggested that retinoblastomas might be sensitive to vitamin D because they sometimes undergo calcification and spontaneous regression. In recent years, the antineoplastic effect of vitamin D has been established in vitro and in vivo. This study presents evidence that vitamin D2 inhibits the growth of the human retinoblastoma cell line (Y-79) grown in athymic mice. In mice treated with ergocalciferol, the subcutaneous retinoblastomas were smaller and showed increased tumor necrosis and calcification. Unfortunately, the vitamin D caused significant toxic reactions. Further studies that reduce the toxicity of vitamin D will be needed before its use in children with retinoblastomas can be advocated. To our knowledge, this is the first demonstration of the activity of ergocalciferol against a tumor in vivo and it suggests that ergocalciferol or one of its derivatives may be an effective chemotherapeutic agent against retinoblastomas in humans.

Original languageEnglish (US)
Pages (from-to)536-540
Number of pages5
JournalArchives of ophthalmology
Volume106
Issue number4
DOIs
StatePublished - Jan 1 1988

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Verhoeff's query: Is vitamin D effective against retinoblastoma?'. Together they form a unique fingerprint.

  • Cite this